MyFinsight
Home
Blog
About
Contact
Back
Income Statement
CytomX Therapeutics, Inc. (CTMX)
CytomX Therapeutics, Inc. (CTMX)
source: myfinsight.com
Download
Download image
Total comprehensive
income (loss)
-$18,257K
(-177.70%↓ Y/Y)
Net income (loss)
attributable to common...
-$18,248K
Unrealized loss on
investments, net of tax
-$9K
(67.86%↑ Y/Y)
Income (loss) before
income taxes
-$18,189K
(-177.11%↓ Y/Y)
Provision for income taxes
$59K
(-4.84%↓ Y/Y)
Interest income
$1,490K
(56.02%↑ Y/Y)
Income (loss) from
operations
-$19,672K
(-186.96%↓ Y/Y)
Revenues
$10,258K
(-79.85%↓ Y/Y)
Other (expense)
income, net
-$7K
(-163.64%↓ Y/Y)
Total operating
expenses
$29,930K
(5.77%↑ Y/Y)
Research and development
$19,238K
(1.96%↑ Y/Y)
General and
administrative
$10,692K
(13.41%↑ Y/Y)
Back